| Bioactivity | CGGRGD TFA, a RGD derivative with cysteine as its N-terminal, CGGRGD TFA is synthesized via solid-phase peptide synthesis technique and the surface of PCL fibers is aminolysised by amino 2-cyanobenzothiazole followed by the addition of 2-cyanobenzothiazole (CBT)[1]. |
| Invitro | CGGRGD TFA is a characteristic sequence of fifibronectin that binds to the receptors on cell surface. (PCL) is a popular materials for tissue engineering due to its optimal biocompatibility, biodegradability, and thermoplastic characteristics[1]. |
| Name | CGGRGD TFA |
| Sequence | Cys-Gly-Gly-Arg-Gly-Asp |
| Shortening | CGGRGD |
| Formula | C21H34F3N9O11S |
| Molar Mass | 677.61 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |